SCHEMBL7078046

SCHEMBL7078046

CCNC(=O)Nc1ccc(Sc2ccc(S(=O)(=O)CC(CC(=O)OCC)c3ccccc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.42
MMP2 P08253 1/20 0.42
MMP8 P22894 1/20 0.42
CA12 O43570 2/20 0.42
CA9 Q16790 2/20 0.42
CASR P41180 2/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
RORC P51449 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MMP13 P45452 7/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
NAMPT P43490 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7077549 0.92 DHODH (0.44) DHODHMMP2MMP8CA12CA9
SCHEMBL7130423 0.89 RORC (0.44) DHODHMMP2MMP8RORCALDH1A1
SCHEMBL7078927 0.87 CA12 (0.44) MMP2CA12CA9CA1CA2
SCHEMBL7074308 0.83 MMP13 (0.45) MMP2CA12CA9CA1CA2
SCHEMBL7078041 0.80 RORC (0.47) DHODHMMP2MMP8RORCALDH1A1
SCHEMBL7136267 0.80 SCN1A (0.43) ALDH1A1MMP13LMNAMAPTHSD17B10
SCHEMBL7078136 0.80 MMP2 (0.58) DHODHMMP2MMP8CA12CA9
SCHEMBL7077769 0.79 HSD17B10 (0.39) MMP2ALDH1A1MMP13HSD17B10
SCHEMBL8360105 0.77 RORC (0.43) DHODHMMP2MMP8CA12CA9
SCHEMBL7074900 0.77 F2 (0.45) MMP8ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed